288 results on '"Jou, Yeong-Chin"'
Search Results
2. Correction to: Species-level characterization of gut microbiota and their metabolic role in kidney stone formation using full-length 16S rRNA sequencing
3. Risk of secondary primary malignancies in survivors of upper tract urothelial carcinoma: A nationwide population-based analysis
4. Hepatic Angiosarcoma Post-Renal Transplantation: A Case Report
5. Sunitinib-related high-grade proteinuria and allograft dysfunction in a kidney recipient: a rare case report
6. Preoperative hydronephrosis is an independent protective factor of renal function decline after nephroureterectomy for upper tract urothelial carcinoma
7. MP38-09 PROGNOSTIC SIGNIFICANCE OF RON AND HER2 RECEPTORS IN UPPER TRACT UROTHELIAL CARCINOMA
8. Ellagic acid protects against angiotensin II‐induced hypertrophic responses through ROS‐mediated MAPK pathway in H9c2 cells
9. Clinicopathologic Analysis of Micropapillary Urothelial Carcinoma of the Upper Urinary Tract: Implications for HER2-Targeted Therapy
10. Tumor distribution affects bladder recurrence but not survival outcome of multifocal upper tract urothelial carcinoma treated with radical nephroureterectomy
11. Peptide-guided JC polyomavirus-like particles specifically target bladder cancer cells for gene therapy
12. Cyproheptadine, an epigenetic modifier, exhibits anti-tumor activity by reversing the epigenetic silencing of IRF6 in urothelial carcinoma
13. Comparison between tubeless mini-percutaneous nephrolithotomy versus flexible ureterorenoscopic lithotripsy for the treatment of upper ureteral calculi larger than 1 cm
14. Antegrade ureteroscopic assistance during percutaneous nephrolithotomy for complete renal staghorn stone: Technique and outcomes
15. Oncologic impact of delay between diagnosis and radical nephroureterectomy
16. Loss of DAB2IP expression in human urothelial carcinoma is associated with poorer recurrence-free survival
17. Abstract 6300: Cyprohepatdine, an anti-histamine and epigenetic modifier, reverses epigenetic silencing of the tumor suppressor IRF6 in urothelial carcinoma
18. The Value of Preoperative Local Symptoms in Prognosis of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Retrospective, Multicenter Cohort Study
19. Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma
20. Prognostic relevance of preoperative circulating CD8-positive lymphocytes in the urinary bladder recurrence of urothelial carcinoma
21. Proteomic Study of Renal Uric Acid Stone
22. Impact of Adjuvant Chemotherapy on Variant Histology of Upper Tract Urothelial Carcinoma: A Propensity Score-Matched Cohort Analysis
23. Additional file 1 of Sunitinib-related high-grade proteinuria and allograft dysfunction in a kidney recipient: a rare case report
24. Outcome of Non-Muscle Invasive Upper Tract Urothelial Carcinoma Receiving Endoscopic Ablation: An Inverse Probability of Treatment Weighting Analysis
25. Factors Predicting Oncological Outcomes of Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma in Taiwan
26. Comparison between tubeless mini-percutaneous nephrolithotomy versus retrograde intrarenal surgery for the treatment of 2 to 3cm renal lithiasis
27. Nadir prostate-specific antigen as a prognostic factor of 10-year cancer-specific survival of prostate cancer patients with bone metastases
28. Loss of nuclear prothymosin-α expression is associated with disease progression in human superficial bladder cancer
29. Clinical relevance of urinary 8‑hydroxydeoxyguanosine levels in patients undergoing prostate biopsy.
30. Determinants and Dynamic Changes of Generic Quality of Life in Human Bladder Cancer Patients
31. Comparing Oncological Outcomes and Surgical Complications of Hand-Assisted, Laparoscopic and Robotic Nephroureterectomy for Upper Tract Urothelial Carcinoma
32. Aberrant Prothymosin-alpha Expression in Human Bladder Cancer
33. Prognostic Relevance of Prothymosin-α Expression in Human Upper Urinary Tract Transitional Cell Carcinoma
34. Safety and efficacy of tubeless percutaneous nephrolithotomy in patients on anti-platelet therapy and cirrhotic patients
35. Anti-Cancer Effects and Tumor Marker Role of Glutathione S-Transferase Mu 5 in Human Bladder Cancer
36. Inducible Nitric Oxide Synthase Promoter Polymorphism, Cigarette Smoking, and Urothelial Carcinoma Risk
37. High-Power Holmium:Yttrium-Aluminum-Garnet Laser for Percutaneous Treatment of Large Renal Stones
38. Innovative Metal Dilators for Percutaneous Nephrostomy Tract: Report on 546 Cases
39. Nephrostomy tube-free percutaneous nephrolithotomy for patients with large stones and staghorn stones
40. The high incidence of JC virus infection in urothelial carcinoma tissue in Taiwan
41. Tubeless mini-percutaneous nephrolithotomy for the treatment of renal and upper ureteral stones of ≥3 cm in diameter
42. Percutaneous nephrolithotomy with holmium: Yttrium-aluminum-garnet laser and fiber guider—report of 349 cases
43. Electrocauterization of bleeding points for percutaneous nephrolithotomy
44. Indoleamine-2,3-dioxygenase-1 expression predicts poorer survival and up-regulates ZEB2 expression in human early stage bladder cancer
45. c-Myc Acts as a Competing Endogenous RNA to Sponge miR-34a, in the Upregulation of CD44, in Urothelial Carcinoma
46. Gene expression and DNA methylation regulation of arsenic in mouse bladder tissues and in human urothelial cells
47. MP57-13 INDOLEAMINE-2,3-DIOXYGENASE -1 EXPRESSION UPREGULATES ZEB2 EXPRESSION THOUGH MICRORNA-200C SIGNALING IN HUMAN BLADDER CANCER
48. History of Urinary Retention Is a Risk Factor for Infection after Prostate Biopsy: A Nationwide, Population-Based Cohort Study
49. Prothymosin‐α enhances phosphatase and tensin homolog expression and binds with tripartite motif‐containing protein 21 to regulate Kelch‐like ECH‐associated protein 1/nuclear factor erythroid 2‐related factor 2 signaling in human bladder cancer
50. Presence of Residual Stones is Not a Contraindication for Tubeless Percutaneous Nephrolithotomy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.